Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
EKZ-001 by Eikonizo Therapeutics for Alzheimer's Disease: Likelihood of Approval
EKZ-001 is under clinical development by Eikonizo Therapeutics and currently in Phase I for Alzheimer's Disease. According to GlobalData, Phase...
Data Insights
EKZ-001 by Eikonizo Therapeutics for Amyotrophic Lateral Sclerosis: Likelihood of Approval
EKZ-001 is under clinical development by Eikonizo Therapeutics and currently in Phase I for Amyotrophic Lateral Sclerosis. According to GlobalData,...